Publications

Affichage de 61 à 70 sur 5406


  • Article dans une revue

Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies

Cyrille Touzeau, Amrita Krishnan, Philippe Moreau, Aurore Perrot, Saad Usmani, Salomon Manier, Michele Cavo, Carmen Martinez Chamorro, Ajay Nooka, Lionel Karlin, Xavier Leleu, Xavier Leleu, Nizar Bahlis, Britta Besemer, Lixia Pei, Sarah Stein, Shun Xin Wang Lin, Danielle Trancucci, Raluca Verona, Suzette Girgis, Xin Miao, Clarissa Uhlar, Katherine Chastain, Alfred Garfall

Abstract Teclistamab is a B-cell maturation antigen (BCMA)–directed bispecific antibody approved for the treatment of patients with triple-class exposed relapsed/refractory multiple myeloma (R/RMM). In the phase 1/2 MajesTEC-1 study, a cohort of patients who had prior BCMA-targeted therapy (…

Blood, 2024, 144 (23), pp.2375-2388. ⟨10.1182/blood.2023023616⟩. ⟨hal-04922674⟩

  • Communication dans un congrès

Enhancing the Forecasting Performance with the Hybrid Machine Learning Techniques for Online Shopping Channels: A Case Study of Electronic Products in Thailand

Anirut Kantasa-Ard, Maroua Nouiri

TENCON 2024 - 2024 IEEE Region 10 Conference (TENCON), Dec 2024, Singapore, France. pp.703-706, ⟨10.1109/TENCON61640.2024.10903046⟩. ⟨hal-04999955⟩

  • Communication dans un congrès

Towards artificial intelligence based rail driving assistance tool

Jean-Valentin Merlevede, Simon Enjalbert, Frédéric Vanderhaegen, Francesco Flammini

This work proposes additional levels of progressive driver assistance expanding the traditional Grades Of Automation (GoA) in order to allow both higher level of automation and keeping the driver involved in driving task at the same time. The second contribution is the Digital Co-Driver (DcD) which…

International Conference on Mobility, Artificial Intelligence and Health (MAIH2024), Cadi Ayyad University, FSTG & FSSM, Morocco, Nov 2024, Marrakesh, Morocco. ⟨10.1051/itmconf/20246903005⟩. ⟨hal-04726618v2⟩

Lu
Ma
Me
Je
Ve
Sa
Di
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
4
5
Effacer
Lu
Ma
Me
Je
Ve
Sa
Di
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
4
5
Effacer